Cardinal Health (NYSE: CAH) reported Q3 EPS of $1.53, $0.07 better than the analyst estimate of $1.46. Revenue for the quarter came in at $31.8 billion versus the consensus estimate of $32.39 billion.

GUIDANCE:

Cardinal Health sees FY2017 EPS of $5.35-$5.36, versus the consensus of $5.50.

Fiscal year 2017 outlook

As previously disclosed, the company does not provide GAAP EPS outlook, because it is unable to reliably forecast most of the items that are excluded from GAAP EPS to calculate non-GAAP EPS. These items could cause EPS to differ materially from non-GAAP EPS. See "Use of Non-GAAP Measures" following the attached schedules for additional explanation.

The company reaffirms its expectation that its fiscal 2017 non-GAAP EPS from continuing operations will be at the bottom of its previous guidance range of $5.35 to $5.50. Additional details about this outlook can be found in the company's press release issued April 18.

For earnings history and earnings-related data on Cardinal Health (CAH) click here.